MP-20X

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMP-20X
Drug Alias NameCannabinoid CB1/5-HT1A receptor modulator (Medipure)MP-20X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor modulatorsCannabinoid CB1 receptor modulators
TargetsCannabinoid CB1 receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsMood DisordersAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesMedipure Holdings
China Registration ClassN/A

Develop Information

Active CompaniesMedipure Holdings
Inactive CompaniesN/A
Active IndicationsMood DisordersAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A